The United States intends to increase restrictions on receiving the Kofid-19 anti-vaccines, while restricting their recommendation to people at the age of 65 and above or more at risk, two high-ranking US officials announced on Tuesday.
The officials in the US Food and Drug Administration (FDA) wrote Marti McCari and Veniak Brasad in an article that this change in politics would allow the American recommendations to be harmonized with those applied by other major developed countries, including the European Union.
They added in the text, published by the “New England Journal of Medicine”, while all other rich countries recommend the vaccination of the elderly (people over the age of 65 years) or people who are infected with a serious condition from Coffee-19, the United States has adopted a unified approach to different age groups.
The US Food and Drug Administration recommendations will be limited to vaccination against Kovid-19 over the ages of 65 years and over, or between the ages of 6 months and 64 years and have at least one risk factor for a risk of disease.
Defining the extensive risk factors from asthma to AIDS, diabetes, obesity, schizophrenia, even smoking, or lack of physical activity.
The Food and Drug Administration will ask pharmaceutical laboratories to conduct clinical trials on the benefits of vaccine for healthy people under the age of 65, according to officials.